Shanghai Sanyou Financials
| 688085 Stock | 21.90 0.84 3.99% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 106.7 M | 114 M |
|
|
Shanghai | Select Account or Indicator |
Understanding current and past Shanghai Sanyou Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Shanghai Sanyou's financial statements are interrelated, with each one affecting the others. For example, an increase in Shanghai Sanyou's assets may result in an increase in income on the income statement.
Please note, the presentation of Shanghai Sanyou's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shanghai Sanyou's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Shanghai Sanyou's management manipulating its earnings.
Shanghai Sanyou Stock Summary
Shanghai Sanyou competes with Kweichow Moutai, Contemporary Amperex, G Bits, Beijing Roborock, and BYD Co. Shanghai Sanyou is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE1000040J7 |
| Business Address | Jiading Industrial Zone, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.sanyoumed.com |
| Phone | 86 21 5838 9980 |
You should never invest in Shanghai Sanyou without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Shanghai Stock, because this is throwing your money away. Analyzing the key information contained in Shanghai Sanyou's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Shanghai Sanyou Key Financial Ratios
Shanghai Sanyou's financial ratios allow both analysts and investors to convert raw data from Shanghai Sanyou's financial statements into concise, actionable information that can be used to evaluate the performance of Shanghai Sanyou over time and compare it to other companies across industries.| Revenue | 460.39 M | ||||
| Gross Profit | 577.77 M | ||||
| EBITDA | 67.9 M | ||||
| Net Income | 91.22 M | ||||
| Total Asset | 2.26 B |
Shanghai Sanyou Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 551.5M | 1.7B | 2.0B | 2.2B | 2.3B | 1.3B | |
| Retained Earnings | 156.9M | 275.4M | 425.7M | 579.2M | 581.5M | 610.5M | |
| Accounts Payable | 67.6M | 65.8M | 20.3M | 28.1M | 100.7M | 105.7M | |
| Cash | 37.5M | 262.5M | 382.3M | 340.4M | 654.4M | 687.1M | |
| Net Receivables | 172.7M | 196.4M | 248.9M | 275.4M | 61.5M | 58.4M | |
| Inventory | 68.2M | 93.2M | 121.5M | 155.1M | 176.7M | 102.9M | |
| Other Current Assets | 64.2M | 4.6M | 14.9M | 27.7M | 28.8M | 23.7M | |
| Total Liab | 113.7M | 136.2M | 260.9M | 278.3M | 218.8M | 154.4M | |
| Total Current Assets | 342.6M | 1.4B | 1.2B | 994.4M | 946.3M | 762.8M | |
| Intangible Assets | 1.5M | 23.8M | 32.8M | 41.0M | 85.6M | 89.9M | |
| Other Current Liab | 27.0M | 32.3M | 89.5M | 81.8M | 616.6K | 585.8K | |
| Other Liab | 7.1M | 12.6M | 23.5M | 31.0M | 35.6M | 37.4M | |
| Net Tangible Assets | 414.9M | 1.5B | 1.3B | 1.5B | 1.7B | 977.4M | |
| Other Assets | 36.3M | 40.1M | 59.9M | 70.1M | 80.6M | 42.8M | |
| Net Invested Capital | 437.8M | 1.5B | 1.7B | 1.8B | 1.9B | 1.3B | |
| Net Working Capital | 236.1M | 1.3B | 915.7M | 749.4M | 751.9M | 694.8M |
Shanghai Sanyou Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 15.9M | 18.4M | 22.2M | 36.0M | 21.2M | 17.6M | |
| Net Interest Income | 124.3K | 3.2M | 7.6M | 9.0M | 15.8M | 16.6M | |
| Interest Expense | 171.4K | 2.9M | 160.7K | 202.8K | 268.1K | 254.7K | |
| Total Revenue | 354.3M | 390.4M | 593.4M | 649.2M | 460.4M | 396.7M | |
| Gross Profit | 323.4M | 354.8M | 537.0M | 585.4M | 368.1M | 348.1M | |
| Operating Income | 115.3M | 112.5M | 152.6M | 189.0M | 114.0M | 106.7M | |
| Ebit | 102.7M | 104.3M | 140.7M | 173.3M | 199.3M | 209.2M | |
| Research Development | 18.4M | 33.9M | 56.6M | 60.4M | 65.2M | 37.5M | |
| Cost Of Revenue | 31.0M | 35.6M | 56.4M | 63.8M | 92.3M | 48.6M | |
| Income Before Tax | 114.0M | 136.9M | 217.3M | 239.5M | 134.9M | 127.4M | |
| Net Income | 97.8M | 118.6M | 186.4M | 190.8M | 95.6M | 104.4M | |
| Interest Income | 188.6K | 3.2M | 7.9M | 9.3M | 16.3M | 17.1M | |
| Ebitda | 120.2M | 144.1M | 233.0M | 258.7M | 297.5M | 155.3M | |
| Income Tax Expense | 15.9M | 18.4M | 22.2M | 36.0M | 41.4M | 43.5M | |
| Minority Interest | (185.8K) | (241.5K) | (8.8M) | (12.7M) | (18.1M) | (17.2M) |
Shanghai Sanyou Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Shanghai Sanyou Medical. It measures of how well Shanghai is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Shanghai Sanyou brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Shanghai had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Shanghai Sanyou has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (29.5M) | (40.4M) | (40.6M) | (55.0M) | (73.6M) | (69.9M) | |
| Investments | 27.2M | (820.4M) | 356.0M | (25.9M) | 51.3M | 53.9M | |
| Change In Cash | 11.7M | 225.0M | 119.9M | (41.9M) | 255.1M | 267.8M | |
| Depreciation | 6.5M | 10.0M | 15.5M | 17.9M | 30.0M | 31.5M | |
| Capital Expenditures | 79.7M | 30.5M | 91.7M | 138.2M | 66.6M | 69.7M | |
| Net Income | 97.8M | 118.6M | 186.4M | 190.8M | 91.2M | 103.8M | |
| End Period Cash Flow | 37.5M | 262.5M | 382.3M | 340.4M | 642.7M | 674.8M | |
| Free Cash Flow | (18.0M) | 47.1M | 53.3M | 17.8M | 160.8M | 168.8M | |
| Other Non Cash Items | 5.6M | 9.7M | 13.0M | 15.3M | 24.3M | 25.5M | |
| Change To Netincome | 5.9M | (14.7M) | (34.6M) | (18.2M) | (16.4M) | (15.5M) |
Shanghai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai Sanyou's current stock value. Our valuation model uses many indicators to compare Shanghai Sanyou value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shanghai Sanyou competition to find correlations between indicators driving Shanghai Sanyou's intrinsic value. More Info.Shanghai Sanyou Medical is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Shanghai Sanyou Medical is roughly 2.25 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai Sanyou by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai Sanyou's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shanghai Sanyou Medical Systematic Risk
Shanghai Sanyou's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shanghai Sanyou volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on Shanghai Sanyou Medical correlated with the market. If Beta is less than 0 Shanghai Sanyou generally moves in the opposite direction as compared to the market. If Shanghai Sanyou Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shanghai Sanyou Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shanghai Sanyou is generally in the same direction as the market. If Beta > 1 Shanghai Sanyou moves generally in the same direction as, but more than the movement of the benchmark.
Shanghai Sanyou Medical Total Assets Over Time
Shanghai Sanyou Thematic Clasifications
Shanghai Sanyou Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Shanghai Sanyou December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shanghai Sanyou help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shanghai Sanyou Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shanghai Sanyou Medical based on widely used predictive technical indicators. In general, we focus on analyzing Shanghai Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shanghai Sanyou's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.08 | |||
| Information Ratio | 0.084 | |||
| Maximum Drawdown | 28.94 | |||
| Value At Risk | (4.09) | |||
| Potential Upside | 5.86 |
Complementary Tools for Shanghai Stock analysis
When running Shanghai Sanyou's price analysis, check to measure Shanghai Sanyou's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Sanyou is operating at the current time. Most of Shanghai Sanyou's value examination focuses on studying past and present price action to predict the probability of Shanghai Sanyou's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Sanyou's price. Additionally, you may evaluate how the addition of Shanghai Sanyou to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world |